Table 9. Predicted ADMET properties for the DAPH molecule and its Ni–DAPH metal complex using the ADMETlab 2.0 and Protox II platforms.
| Compounds | PPBa (%) | BBBb | HIAc | CLd | T 1/2 e | LD50f (mg kg−1) | TPSAg (Å2) | Based on Lipinski rule | Lipinski's violation | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NHDh | NHAi | NRBj | MWk(g mol−1) | MLOGPl | |||||||||
| DAPH | 78.77 | 0.004 | 0.012 | 13.611 | 1.375 | 1540 | 70.67 | 2 | 4 | 0 | 178.03 | 0.772 | 0 |
| Ni–DAPH | 99.12 | 0.004 | 0.96 | 5.989 | 0.957 | 5370 | 247.87 | 8 | 16 | 4 | 776.09 | 4.071 | 3 |
Plasma Protein Binding.
Blood–Brain Barrier Penetration.
Human Intestinal Absorption.
Plasma Clearance.
half-life drugs.
Lethal Dose.
Topological polar surface area.
Number of hydrogen bond donors.
Number of hydrogen bond acceptors.
Number of rotatable bonds.
Molecular weight.
calculated lipophilicity.